Dominica vs Monaco: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Dominica
0.0%
in 2025
Monaco
0.0%
in 2025
Dominica rank
165th
Monaco rank
165th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Dominica
- Monaco
How they compare
Dominica currently reports 0.0% against 0.0% in Monaco, a difference of 0.0%.
Across all 18 years both countries report, Monaco has been ahead every year.
Dominica ranks 165th and Monaco ranks 165th of 192 countries.
Head to head by decade
| Decade | Dominica | Monaco | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | β |
| 2010s | 0.0% | 0.0% | 0.0% | β |
| 2020s | 0.0% | 0.0% | 0.0% | β |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Dominica or Monaco?
- Dominica, at 0.0% against 0.0% in Monaco as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Dominica and Monaco?
- 0.0%, with Dominica ahead.
- How many years of comparable data are there for Dominica and Monaco?
- 18 years are reported by both, from 2008 to 2025.
- How do Dominica and Monaco rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Dominica ranks 165th and Monaco ranks 165th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.